Home > Insider Trading > Filing (0001127602-13-014777)

Filing Details

Accession Number:: 0001127602-13-014777
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-30 17:21:10
Reporting Period:: 2013-04-26

Filing Date:: 2013-04-30
Accepted Time:: 2013-04-30 17:21:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
318154	Amgen Inc	AMGN	Biological Products, (No Disgnostic Substances) (2836)	953540776

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1183885	M Brian Mcnamee	One Amgen Center Drive Thousand Oaks CA 91320-1799	Svp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-04-26	10,000	$58.43	66,077	No	4	M	Direct
Common Stock	Disposition	2013-04-26	10,000	$107.99	56,077	No	4	S	Direct
Common Stock	Disposition	2013-04-26	723	$108.66	55,354	No	4	F	Direct
Common Stock	Disposition	2013-04-28	711	$108.38	54,643	No	4	F	Direct
Common Stock	Acquisiton	2013-04-29	10,000	$50.44	64,643	No	4	M	Direct
Common Stock	Disposition	2013-04-29	10,000	$107.02	54,643	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	F	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nqso (Right to Buy)	Disposition	2013-04-26	10,000	$0.00	10,000	$58.43
Common Stock	Nqso (Right to Buy)	Disposition	2013-04-29	10,000	$0.00	10,000	$50.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000	2011-04-26	2020-04-26	No	4	M	Direct
0	2010-04-28	2016-04-28	No	4	M	Direct

Footnotes

The price reported is an average price. The prices ranged from $107.96 to $108.00 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
The price reported is an average price. The prices ranged from $106.8707 to $107.1316 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 5,025 RSUs which vest in one installment of 2,475 on 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 106 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.